A Phase Ib, Open-Label, Dose Escalation Trial Investigating Different Doses And Schedules Of Sym004 In Combination With Platinum-Doublets In Subjects
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Drug
The purpose of a Phase I study is to find the best way to give an investigational drug (for example, by mouth, intravenous infusion, or injection) and/or the best dose. In Phase I studies, the dose is usually increased a little at a time until several participants have serious side effects.
To Qualify For This Study You Must Have Been Diagnosed With Stage Iv Nsclc.
Cancer, Lung, Emr200637-003, Nsclc, Stage Iv
For More Information:
Uc Cancer Institute